AADI
|
Aadi Biosciences, Inc.
|
US
|
NASDAQ
|
ACRV
|
Acrivon Therapeutics, Inc.
|
US
|
NASDAQ
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
ARAY
|
Accuray Incorporated
|
US
|
NASDAQ
|
AURA
|
Aura Biosciences, Inc.
|
US
|
NASDAQ
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
BCYC
|
Bicycle Therapeutics plc
|
US
|
NASDAQ
|
BIOC
|
Biocept, Inc.
|
US
|
NASDAQ
|
BNR
|
Burning Rock Biotech Limited
|
US
|
NASDAQ
|
BOLT
|
Bolt Biotherapeutics, Inc.
|
US
|
NASDAQ
|
CADL
|
Candel Therapeutics, Inc.
|
US
|
NASDAQ
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
CMPX
|
Compass Therapeutics, Inc.
|
US
|
NASDAQ
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
CSBR
|
Champions Oncology, Inc.
|
US
|
NASDAQ
|
ENLV
|
Enlivex Therapeutics Ltd.
|
US
|
NASDAQ
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|